In-silico trial of intracranial flow diverters replicates and expands insights from conventional clinical trials

Published by Nature Communications

Clinical TrialsIn silicovirtual patients

In-silico trials rely on virtual populations and interventions simulated using patient-specific model and may offer a solution to lower these costs. In this article, It is presented the flow diverter performance assessment (FD-PASS) in-silico trial, which model the treatment of intracranial aneurysms in 164 virtual patients with 82 distinct anatomies with a flow-diverting stent, using computational fluid dynamics to quantify post-treatment flow reduction

View this resource Bookmark this resource